The Role of Progestogens in Peri- and Post-menopausal Hormone Replacement Therapy: Proceedings of a Workshop Held at Sussex University on 20 and 21 September 1977B. I. Hoffbrand |
Contents
Discussion | 15 |
Session II | 25 |
Coagulation factors in opposed and unopposed oestrogen treatment at the climacteric | 31 |
Copyright | |
11 other sections not shown
Common terms and phrases
acetate activity addition administration appear assay associated AYLWARD bone breakthrough bleeding CAMPBELL cancer castrated changes climacteric Clinical combined compared condition conjugated curettage cycle cyclical high-dose cyclical oestrogen developed dosage dose effect endometrial carcinoma endometrial hyperplasia et al evidence exogenous factors further given hormone Hospital human important incidence increase indicate Journal levels low-dose mean measured Medical menopause methods mg daily months norethisterone norgestrel normal endometrium Obstetrics obtained occurred oestradiol valerate oestrogen therapy oestrogen/progestogen oestrone oral patients pattern performed period phase piperazine plasma post-menopausal Premarin present produce PROFESSOR progesterone progestogen range ratio rats received receptor reduced References regimens regular replacement therapy reported Research response samples sequential therapy serum showed shown significant similar stimulation subsequent suggest symptoms Table testosterone tests treated treatment unopposed urinary uterine vaginal bleeding values week Whitehead withdrawal bleeding women